Rocket One Inc. Other Noncash Expense
Rocket One Inc. (RKTO) reported Other Noncash Expense of $1.03 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2026-03-27
- Rocket One Inc. other noncash expense for the quarter ending 2025-12-31 was -$1.11K.
- Rocket One Inc. other noncash expense for the quarter ending 2025-09-30 was -$1.11K.
- Rocket One Inc. other noncash expense for fiscal 2025 was $1.03K.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 6 month | Other Noncash Expense 9 month | Other Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$1.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$2.22K derived: sum of 2 quarters · filed 2026-03-27 | $1.03K 10-K · filed 2026-03-27 | |
| 2025-09-30 | -$1.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.13K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $3.25K 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |